Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 02, 2022
Cambrex announced it is significantly expanding its existing biopharmaceutical testing services business. The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecule and...
read more
Cambrex Corporation will expand research and development capabilities at its site in Paullo, Milan, Italy.
read more
Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts to further support the development and manufacturing of peptide therapies.
read more
Tuesday, January 30, 2018
Cambrex announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant.
read more
Cambrex announced it is investing $3.6 million at its Karlskoga, Sweden facility to increase flexible drug substance manufacturing capacity.
read more
Cambrex announced the completion of an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale laboratory to undertake the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) ...
read more
Cambrex announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing.
read more
Wednesday, August 09, 2017
Cambrex Corporation announced that it is to invest $24 million in a new facility to manufacture highly potent APIs (HPAPIs) at its Charles City, Iowa plant.
read more
Cambrex announced that it is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its site in Paullo, Milan, Italy.
read more
Thursday, October 12, 2017
Cambrex has made a number of investments, in both R&D and manufacturing capabilities to support the development and production of generic APIs, at its site in Paullo, Milan, Italy.
read more
Wednesday, August 30, 2017
Cambrex, announced it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory.
read more
Cambrex announced that it has expanded large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden.
read more
Cambrex has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility.
read more
Cambrex announced it will start a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site.
read more
Wednesday, November 08, 2017
Cambrex announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant.
read more